Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02093611 · ClinicalTrials.gov registry record · NA
Study to Examine the Effects of ATP Supplementation on Muscle Excitability and Reaction Time During and Following a Repeated Sprint Bout
A NA study, sponsored by Metabolic Technologies.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02093611 is a NA study that has completed, run by Metabolic Technologies. The registered enrollment target is 42 participants.
The verdict
NCT02093611, a NA study, has completed, sponsored by Metabolic Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
We hypothesize that adenosine-5'-triphosphate (ATP) supplementation will be able to enhance motor unit recruitment while simultaneously blunting the decline in power and reaction time that is typically seen during repetitive sprints. This will give researchers a better understanding of the mechanism by which ATP supplementation can augment power, especially under high fatiguing conditions.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT ATP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02093611
The ClinicalTrials.gov registry entry for NCT02093611 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Metabolic Technologies, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02093611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02093611 about?
NCT02093611 is a clinical study titled "Study to Examine the Effects of ATP Supplementation on Muscle Excitability and Reaction Time During and Following a Repeated Sprint Bout". We hypothesize that adenosine-5'-triphosphate (ATP) supplementation will be able to enhance motor unit recruitment while simultaneously blunting the decline in power and reaction time that is typically seen during repetitive sprints. This will give researchers a better understanding of the mechanism...
What is the current status of trial NCT02093611?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2013-07. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02093611?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), ATP (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02093611?
This trial is sponsored by Metabolic Technologies, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.